Short description
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Description
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases. Plexium's platform focuses on the discovery of next-generation TPD drugs that extend beyond the limited applications of Proteolysis Targeting Chimeras (PROTACs) and cereblon imids, unraveling the boundless possibilities of true drug-like protein degraders. From molecular glues to monovalent degraders, the possibilities are endless across a wide variety of therapeutic areas.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
San Diego, California, United States, North America
Founded on
January 1, 2018
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noway Youcantaccess, Cannot Access, Noway Youcantaccess, Cannot Access, Uh Ohhhh, No Way, Noaccessforu, Noaccess, Noaccess, No Way, Blurry Noaccess, Uh Ohhhh
Sign in for full access
Founders
Andrew MacConnell, Joe Rokicki